Fluoxetine in the treatment of premenstrual dysphoria

Neuropsychopharmacology

Volumn 16, Issue 5, 1997, Pages 346-356

  Su, Tung Ping ^a   Schmidt, Peter J ^a   Danaceau, Merry A ^a   Tobin, Marie B ^a   Rosenstein, Donald L ^a   Murphy, Dennis L ^a   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

fluoxetine; follicular phase; luteal phase; m chlorophenylpiperazine (m CPP); premenstrual dysphoric disorder (PMDD); serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; FLUOXETINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPHORIA; FEMALE; HUMAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MIDDLE AGED; PERSONALITY INVENTORY; PIPERAZINES; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; SELF ASSESSMENT (PSYCHOLOGY); SEROTONIN AGONISTS;

EID: 0030956705     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00245-X     Document Type: Article

References (49)

1. Abraham GE, Swerdloff R, Tulchinsky D, Odell WD (1971): Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab 32:619-624
2. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Press
3. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G (1991): Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 21:305-312
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961): An inventory for measuring depression. Arch Gen Psychiatr 4:561-571
5. Bowden CL, Schatzberg AF, Rosenbaum A, Contreras SA, Samson JA, Dessain E, Sayler M (1993): Fluoxetine and desipramine in major depressive disorder, J Clin Psychopharmacol 13:305-311
6. Brandenbrug S, Tuynman-Qua H, Verheij R, Pepplinkhuizen L (1993): Treatment of premenstrual syndrome with fluoxetine: An open study. Int Clin Psychopharmacol 8:313-317
7. Brosen K (1993): The pharmacogenetics of the selective serotonin reuptake inhibitors. Clin Invest 71:1002-1009
8. Brzezinski AA, Wurtman JJ, Wurtman RJ, Gleason R, Greenfield J, Nader T (1990): d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstet Gynecol 76:296-301
9. Caccia S, Anelli M, Codegoni AM, Fracasso C, Garattini S (1993): The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. Br J Pharmacol 110:355-359
10. Carroll BJ (1994): Are SSRI antidepressants clinically homogeneous? Lancet 344:550
11. Daaman MJ, Brown WA (1992): Single-dose fluoxetine in management of premenstrual syndrome. J Clin Psychiatr 53:210-211
12. Endicott J, Halbreich U (1982): Retrospective report of premenstrual depressive changes: Factors affecting confirmation by daily ratings. Psychopharmacol Bull 18:109-112
13. Eriksson E, Lisjo P, Sundblad C, Andersson K, Andersch B, Modigh K (1990): Effect of clomipramine on premenstrual syndrome. Acta Psychiatr Scand 81:87-88
14. Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG (1991): Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatr 52:329-335
15. Freeman EW, Rickels K, Sondheimer SJ, Denis A, Pfeifer S, Weil S (1994): Nefazodone in the treatment of premenstrual syndrome: A preliminary study. J Clin Psychopharmacol 14:180-186
16. German JM, Liebowitz MR, Fyer AJ, Goetz D, Campeas RB, Eyer MR, Davies SO, Klein DF (1987): An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 7:329-332
17. Halbreich U (1990): Gonadal hormones and antihormones, serotonin and mood. Psychopharmacol Bull 26:291-295
18. Halbreich U, Endicott J, Lesser J (1985): The clinical diagnosis and classification of premenstrual changes. Can J Psychiatr 30:489-497
19. Harrison WM, Endicott J, Nee J (1990): Treatment of premenstrual dysphoria with alprazolam: A controlled study. Arch Gen Psychiatr 47:270-275
20. Herman JB, Brotman AW, Pollack MH (1990): Fluoxetine-induced sexual dysfunction. J Clin Psychiatr 51:25-27
21. Hollander E, Stein DJ, DeCaria CM, Saoud JB, Klein DF, Liebowitz MR (1993): A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biol Psychiatr 33:747-749
22. Jacobsen FM (1992): Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatr 53:119-122
23. Magyar DM, Boyers SP, Marshall JR, Abraham GE (1979): Regular menstrual cycles and premenstrual molimina as indicators of ovulation. Obstet Gynecol 53:411-414
24. Menkes DB, Taghavi E, Mason PA, Spears GFS, Howard RC (1992): Fluoxetine treatment of severe premenstrual syndrome. Br Med J 305:346-347
25. Menkes DB, Taghavi E, Mason PA, Howard RC (1993): Fluoxetine's spectrum of action in premenstrual syndrome. Int Clin Psychopharmacol 8:95-102
26. Murphy DL, Mueller EW, Hill JL, Tolliver TJ, Jacobsen FM (1989): Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology 98:275-282
27. Mustafa AA, Alhaider AA (1993): Differential effects of fluoxetine on isoprenaline-stimulated water intake in ethanol-treatment rats: A role for beta-adrenoceptors. Eur J Pharmacol 237:147-154
28. Pearlstein TB, Stone AB (1994): Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatr 55:332-335
29. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver, TJ, Murphy DL (1990): Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: Behavioral and biological results. Arch Gen Psychiatr 47:926-932
30. Rickels K, Freeman E, Sondheimer S (1989): Buspirone in treatment of premenstrual syndrome. Lancet 1:777
31. Sacchetti E, Conte G, Guarneri L (1994): Are SSRI antidepressants a clinically homogeneous class of compounds? Lancet 344:126-127
32. Schmidt PJ, Grover GN, Rubinow DR (1993): Alprazolam in the treatment of premenstrual syndrome: A double-blind, placebo-controlled trial. Arch Gen Psychiatr 50:467-473
33. Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF (1990): Fluoxetine in panic disorder. J Clin Psychopharmacol 10:119-121
34. Smith S, Rinehart JS, Ruddock VE, Schiff I (1987): Treatment of premenstrual syndrome with alprazolam: Results of a double-blind, placebo-controlled, randomized cross-over clinical trial. Obstet Gynecol 70:37-43
35. Spielberger CB, Gorsuch RL, Luschene RE (1970): STAI manual for the state-trait anxiety inventory. Palo Alto, CA, Consulting Psychologists Press
36. Spitzer RL, Williams JB, Gibbon M, First MB (1989): Structured Clinical Interview for DSM-III-R, Patient Edition. New York, Biometrics Research Department, New York State Psychiatric Institute
37. Spoont MR (1992): Modulatory role of serotonin in neural information processing: Implications for human psychopathology. Psychol Bull 112:330-350
38. Stark P, Hardison CD (1985): A review of multicenter controlled studies of fluoxetine versus imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatr 46:53-58
39. Steinberg S, Annable L, Young SN, Beanger M (1994): Tryptophan in the treatment of late luteal phase dysphoric disorder: A pilot study. J Psychiatr Neurosci 19:114-119
40. Steiner M, Haskett RF, Carroll BJ (1980): Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 62:177-190
41. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D (1995): Fluoxetine in the treatment of premenstrual syndrome. N Engl J Med 332:1529-1534
42. Stone AB, Pearlstein TB, Brown WA (1991): Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatr 52:290-293
43. Sundblad S, Modigh K, Andersch B, Eriksson E (1992): Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo-controlled trial. acta Psychiatr Scand 85:39-47
44. Sundblad C, Hedberg MA, Eriksson E (1993): Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial. Neuropsychopharmacology 9:133-145
45. Teicher MH, Glod C, Cole JO (1990): Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatr 147:207-210
46. Tollefson GD, Rampey Jr AH, Potvin JH, Jenike MA, Rush AJ, Dominguez RA, Koran LM, Shear K, Goodman W, Genduso LA (1994): A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatr 51:559-567
47. VanKammen DP, Murphy DL (1975): Attenuation of the euphoriant and activating effects of d-and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215-224
48. Veeninga AT, Westenberg HGM, Weusten JTN (1990): Fluvoxamine in the treatment of menstrually related mood disorders. Psychopharmacology 102:414-416
49. Wood SH, Mortola JF, Chan Y, Moossazadeh F, Yen SSC (1992): Treatment of premenstrual syndrome with fluoxetine: A double-blind, placebo-controlled, crossover study. Obstet Gynecol 80:339-344